Posts Tagged ‘obesity’

Gee Whizzy New Drugs for Weight Loss or Obesity

March 13, 2024 — The drug development pipeline is filling up with new new drugs for weight loss or obesity. On Thursday, Novo Nordisk caused the hearts of investors to flutter when it presented topline results on an oral medicine that might be more effective than semaglutide. The value of the company’s stock jumped by 13%. Just a week […]

Well-Meant, but Promoting Weight Bias and Discrimination

March 12, 2024 — “We must support people living with obesity by educating them about healthy lifestyles.” This is #4 in a series of well-meant statements that promote weight bias and discrimination. Such a statement purports to mean well. But there are so many problems with comments like this that it’s difficult to summarize them all in a short […]

Scarcity, Greed, and Drug Pricing in an Election Year

March 10, 2024 — For many of us, it’s just too painful to think about. But a rerun of the 2020 presidential election is coming and drug pricing is likely to be a big talking point for both of the major candidates. President Biden is talking about corporate greed while former President Trump is talking about reviving an executive […]

Indication for Heart Health Marks a New Era in Obesity Treatment

March 9, 2024 — It’s official. FDA now says that semaglutide, in doses used to treat obesity, can prevent heart attacks, strokes, and deaths in persons with cardiovascular disease and overweight or obesity. This is nothing short of the dawn of a new era in obesity treatment. FDA Division Director John Sharretts said it clearly: “This patient population has […]

Obesity Care Week: Sneaky Stigma Stalks Us

March 8, 2024 — Today, we are putting a bow on Obesity Care Week by coming back to a root problem that gets in the way of reducing the harm of obesity – stigma. It causes psychological distress for the people living with this disease and leads them to avoid medical care. Explicit weight bias has become less acceptable […]

Obesity Care Week: New Roles for Old Tools of Care

March 7, 2024 — Obesity Care Week this year comes at a time when we have shiny new tools for treating obesity that are garnering a whole lot of attention. One would have be living under a rock not to have heard all the buzz about semaglutide, tirzepatide, and a host of other medicines coming soon for obesity. But […]

Obesity Care Week: Equity for a Treatable Chronic Disease

March 6, 2024 — One of the core principles Obesity Care Week is that this chronic disease is treatable. That’s becoming plain to see with emergence of advanced GLP-1 therapies. But equity in access to obesity care is practically non-existent. Prices for these medicines are high, supplies are low, and health plans make a sport of torturing people who […]

Obesity Care Week: Five Enduring Principles

March 5, 2024 — On this, the second day of Obesity Care Week, let’s step back from all the complexity of obesity and focus on five simple principles that hold great promise for improving the way we care for people with this disease. It really doesn’t have to be so hard. 1. It Is Undeniable That Obesity Is a […]

Pretending to Keep the Cost of Treating Obesity Down

March 4, 2024 — Today marks the start of Obesity Care Week and all over the globe, this is World Obesity Day. To mark this day, dozens of advocates from all of the major organizations that care about improving the standard of care for obesity have converged on the U.S. Capitol for dialog with policymakers about opening the pathway […]

Health Systems Hindering Health for People with Obesity

March 1, 2024 — In a new cohort study, it is plain to see that, even before the advent of new GLP-1 medicines for obesity, primary care patients could get better health from obesity care. But health systems hindering delivery of obesity care make this exceedingly unlikely for most people living this disease. A Large Cohort Study from an […]